Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Other Working Capital Changes (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Other Working Capital Changes data on record, last reported at $3.1 million in Q1 2013.

  • For Q1 2013, Other Working Capital Changes rose 441.42% year-over-year to $3.1 million; the TTM value through Mar 2013 reached $3.2 million, up 1186.85%, while the annual FY2025 figure was $181000.0, 212.42% up from the prior year.
  • Other Working Capital Changes reached $3.1 million in Q1 2013 per SNOA's latest filing, up from -$4.3 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $4.5 million in Q3 2012 and bottomed at -$4.3 million in Q4 2012.
  • Average Other Working Capital Changes over 4 years is $321333.3, with a median of -$38500.0 recorded in 2010.
  • The widest YoY moves for Other Working Capital Changes: up 3084.0% in 2012, down 7327.59% in 2012.
  • A 4-year view of Other Working Capital Changes shows it stood at $623000.0 in 2010, then plummeted by 109.31% to -$58000.0 in 2011, then tumbled by 7327.59% to -$4.3 million in 2012, then surged by 171.01% to $3.1 million in 2013.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $3.1 million in Q1 2013, -$4.3 million in Q4 2012, and $4.5 million in Q3 2012.